CSL Investor Relations Material
Latest events
H1 2025
CSL
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CSL Limited
Access all reports
CSL Limited is a global biotechnology company specializing in the development and manufacture of products that treat serious human medical conditions. It operates across segments such as biotherapies, vaccines, and plasma protein therapies, serving the healthcare sector. CSL provides critical biological medicines to healthcare providers worldwide through its research, development, and manufacturing operations. The company is headquartered in Melbourne, Australia, and its shares are listed on the ASX.
Key slides for CSL Limited
Shareholder Briefing
CSL Limited
Shareholder Briefing
CSL Limited
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
CSL
Country
🇦🇺 Australia